These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33435649)

  • 1. Clinicopathological significance of epidermal growth factor receptor expression in papillary thyroid carcinoma: a meta-analysis.
    Qin XR; Huang JK; Yin QF; Shi XM; Tang JC; Hao LL; Li PF; Zhu J; Wang YX
    Minerva Endocrinol (Torino); 2024 Jun; 49(2):175-181. PubMed ID: 33435649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
    Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
    Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
    Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
    J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis.
    Wen J; Qin X; Zhang J; Wu X; Yan X; Lu K; Yang P; Ji S; Zhao X; Wang Y
    World J Surg Oncol; 2023 Jul; 21(1):225. PubMed ID: 37496069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective factor against lymph node metastasis of papillary thyroid cancer: Female gender.
    Shi P; Yang D; Liu Y; Zhao Z; Song J; Shi H; Wu Y; Jing S
    Auris Nasus Larynx; 2023 Jun; 50(3):440-449. PubMed ID: 36253315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of chemokine receptor CXCR4 expression in papillary thyroid carcinoma: a meta-analysis.
    Wu Z; Cao Y; Jiang X; Li M; Wang G; Yang Y; Lu K
    Minerva Endocrinol; 2020 Mar; 45(1):43-48. PubMed ID: 29424203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
    Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
    Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
    Yan B; Hou Y; Chen D; He J; Jiang Y
    Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
    Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
    Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
    Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
    Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Tang C; Yang L; Wang N; Li L; Xu M; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2014; 7(6):3213-23. PubMed ID: 25031742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
    Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
    Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer.
    Ma H; Wang R; Fang J; Zhong Q; Chen X; Hou L; Feng L; Chen X; Huang Z; Zhao H
    Medicine (Baltimore); 2020 Jan; 99(5):e18917. PubMed ID: 32000400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.
    Ahn HY; Song RY; Ahn HS; Kim HS
    Cancer Res Treat; 2021 Oct; 53(4):1204-1212. PubMed ID: 33592140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonography-Guided Thermal Ablation for Cervical Lymph Node Metastasis of Recurrent Papillary Thyroid Carcinoma: Is it Superior to Surgical Resection?
    Zhang X; Ni T; Zhang W
    Front Endocrinol (Lausanne); 2022; 13():907195. PubMed ID: 35832431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
    Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
    J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma.
    Huang Y; Chang A; Zhou W; Zhao H; Zhuo X
    Clin Exp Med; 2020 Nov; 20(4):515-525. PubMed ID: 32596748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
    Li C; Lee KC; Schneider EB; Zeiger MA
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4559-70. PubMed ID: 23055546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients.
    Lu Y; Jiang L; Chen C; Chen H; Yao Q
    Medicine (Baltimore); 2020 Apr; 99(15):e19795. PubMed ID: 32282744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.